Ferric maltol Real-world Effectiveness Study in Hospital practice (FRESH): clinical characteristics and outcomes of patients with inflammatory bowel disease receiving ferric maltol for iron-deficiency anaemia in the UK.

J R Fraser CummingsAileen FraserCatherine StansfieldIan BealesShaji SebastianSami Hoque

Published in: BMJ open gastroenterology (2021)

Ferric maltol increases haemoglobin and iron indices and is generally well tolerated in patients with IBD and IDA treated in clinical practice. These real-world data support findings from randomised controlled trials.

Keyphrases

iron deficiency
patients with inflammatory bowel disease
clinical practice
healthcare
randomized controlled trial
primary care
systematic review
electronic health record
cross sectional
type diabetes
emergency department
adverse drug
deep learning